Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
179
Total Claims
$68K
Drug Cost
25
Beneficiaries
$2,712
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+773%
Opioid rate vs peers
54.7% vs 6.3% avg
-80%
Cost per patient vs peers
$2,712 vs $14K avg
-1%
Brand preference vs peers
14.5% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 773% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
54.7%
Opioid Rate
98
Opioid Claims
$1,415
Opioid Cost
—
Long-Acting Rate
This provider's opioid prescribing rate of 54.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 26 claims · $45K
Generic: 153 claims · $23K
Patient Profile
42
Avg Age
—
Female
4.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About